← Open Payments lookup

LIZ NAPASINDAYAO: Open Payments

NPI 1407500614 · SAN CARLOS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,416 in 83 payments from 21 companies in 2025. Trend: 2023 $3,292 · 2024 $3,667 · 2025 $4,416

Food & beverage: $4,317Education: $99
CompanyPaymentsAmount
ABBVIE INC.28$978
Madrigal Pharmaceuticals7$585
Janssen Biotech, Inc.7$455
Lilly USA, LLC7$358
Gilead Sciences, Inc.7$329
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$239
Phathom Pharmaceuticals, Inc.4$195
Genentech USA, Inc.1$144
MDD US Operations, LLC1$143
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$129

Products named: REZDIFFRA, LINZESS, TREMFYA, CREON, OMVOH, XIFAXAN, VOQUEZNA, Ocrevus.

Industry payments across CA — which companies pay providers there.